For research use only. Not for therapeutic Use.
GPR41 agonist-1 (compound 9) is a potent GPR41 agonist. GPR41 agonist-1 can be used for researching insulin-related disorders[1].
Catalog Number | I043366 |
CAS Number | 506417-09-0 |
Synonyms | 2-methyl-N-(2-methylphenyl)-4-(3-nitrophenyl)-5-oxo-4,6,7,8-tetrahydro-1H-quinoline-3-carboxamide |
Molecular Formula | C24H23N3O4 |
Purity | ≥95% |
InChI | InChI=1S/C24H23N3O4/c1-14-7-3-4-10-18(14)26-24(29)21-15(2)25-19-11-6-12-20(28)23(19)22(21)16-8-5-9-17(13-16)27(30)31/h3-5,7-10,13,22,25H,6,11-12H2,1-2H3,(H,26,29) |
InChIKey | UWQXWOJVNASZLI-UHFFFAOYSA-N |
SMILES | CC1=CC=CC=C1NC(=O)C2=C(NC3=C(C2C4=CC(=CC=C4)[N+](=O)[O-])C(=O)CCC3)C |
Reference | [1]. James N. Leonard, et al. Gpr41 and modulators thereof for the treatment of insulin-related disorders. WO2006052566A2. |